Browsing Tag
PTSD
134 posts
Claims of Misconduct Mar MDMA Research for PTSD
Clinical trials investigating the psychedelic MDMA as a treatment for PTSD are facing claims of research challenges and allegations of misconduct that could mar the results of the research.
Yale Researchers To Study Psilocybin for PTSD, Mental Conditions
A study cohort will examine the efficacy of psilocybin for the treatment of issues like PTSD and addiction.
Atlanta Lawmaker Pushes City To Study Psilocybin, Ketamine Treatments
Psychedelic therapy could be coming to Atlanta.
Psychedelic Research Proves Rather Tricky for the FDA
Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.
Study Reveals State Cannabis Legalization Lowers Immigrant Deportation
There's just a false sense of security related to the federal government to worry about.
Study Finds Natural Mushroom Extract Has Better Therapeutic Effects Than Synthesized Psilocybin
New research shows that natural mushroom extracts may have unique therapeutic effects compared to synthesized psilocybin.
Missouri House Committee Passes Psilocybin Legalization Bill for Military Veterans
The House bill, in conjunction with an identical Senate bill passed in February, would legalize psilocybin for veterans and provide funds to study the substance.
Study Shows MDMA Enhances Emotional Response to Positive Social Interactions
The results of a recent study show that MDMA can enhance feelings of happiness and connection during positive social interactions and may have the potential to treat mental health conditions including PTSD.
Ukraine Introduces Medical Pot To Aid in Healing Trauma of Conflict with Russia
It's estimated over six million people will benefit from cannabis.
Ukraine MMJ Bill Unblocked After Repeal Effort Fails To Receive Needed Votes
Ukraine’s measure to legalize medical cannabis is once again headed to the president’s desk after the opposing Batkivshchyna party moved to appeal the bill to the Constitutional Court to cancel the legislative vote in December 2023, ultimately failing to receive adequate support for repeal.